ORIGINAL ARTICLESUse of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs
REFERENCES (29)
- et al.
Assessing the quality of asthma care provided to Medicaid patients enrolled in managed care organizations in Connecticut
Ann Allergy Asthma Immunol.
(2001) - et al.
Poverty, race, and medication use are correlates of asthma hospitalization rates: a small area analysis in Boston
Chest.
(1995) - et al.
Prescribing and hospital admissions for asthma in east London
BMJ.
(1996) Long-term effects of budesonide or nedocromil in children with asthma
N Engl J Med.
(2000)- et al.
First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
Thorax.
(1998) - et al.
Low-dose inhaled corticosteroids and the prevention of death from asthma
NEngl JMed.
(2000) - et al.
Inhaled steroids and the risk of hospitalization for asthma
JAMA.
(1997) Management of Chronic Asthma
(2001)Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
(1997)Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention: Revised 2002
(2002)
Use of inhaled anti-inflammatory medication in children with asthma in managed care settings
Arch Pediatr Adolesc Med.
Asthma symptoms, morbidity, and antiinflammatory use in inner-city children
Pediatrics.
Young inner-city children visiting the emergency room (ER) for asthma: risk factors and chronic care behaviors
J Asthma.
Underuse of controller medications among medicaid-insured children with asthma
Arch Pediatr Adolesc Med.
Cited by (26)
46 - Severe Asthma
2019, Kendig's Disorders of the Respiratory Tract in ChildrenPrescription fill patterns in underserved children with asthma receiving subspecialty care
2013, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :The current asthma treatment guidelines recommend that persistent asthma should be treated as a chronic illness with daily inhaled steroid therapy rather than urgently, when exacerbations occur.3 Improved asthma outcomes are clearly related to asthma controller medication use.4–6 Adherence to controller asthma medication regimens is less than ideal, especially in underserved populations.7–9
Improving parental adherence with asthma treatment guidelines: A randomized controlled trial of an interactive website
2012, Academic PediatricsCitation Excerpt :Adherence was measured by asking parents: “During a recent typical week, on how many days has your child used a given controller medicine (Name)” There were 5 options for answers: 0 days per week, 1−2 days per week, 3−4 days per week, 5−6 days per week, and 7 days per week. We defined being compliant with taking controller medications at least once per day for 5 or more days per week because this has been used in previous studies and the benefits of regular usage are discernible at that level of adherence.32 Adherence was only measured when parents reported that a child was currently using a controller medication.
Management of severe asthma in children
2010, The LancetCitation Excerpt :In our series, treatment-related issues (such as inappropriate use of drug delivery devices, non-adherence to treatment regimens, and out-of-date drugs), contributed to poor control in about half the patients. Another important use of prescription records is to identify which patients collect excessive prescriptions of short-acting β2 agonists; collecting six or more per year was associated with a poor outcome in a community-based study.53 Data from many studies suggest that active smoking by adults with asthma leads to steroid resistance,61–64 and exposure to passive smoke probably has the same effect.
Continuity of prescribers of short-acting beta agonists among children with asthma
2009, Journal of PediatricsCitation Excerpt :Logistic regression, with generalized estimating equations to account for the correlation among children assigned the same PCP,38,39 was used to model the association between SABA prescriber continuity and ED visits, adjusting for demographic, PCP and specialist SABA prescriber variables, and asthma severity/control. Similar to other studies, our analyses were adjusted with proxy variables representing baseline (2004) measures of severity including SABA use,10,16,18,20,26,27,32,40-42 controller use,9,40,43 hospitalizations,17,27,40,43-48 asthma-related ED visits,27,40,42,44-46 and outpatient asthma care.18,49 Controller medication use was dichotomized as having none or ≥1 filled prescriptions50; similarly, hospitalizations, ED visits, and asthma-related outpatient visits were classified as none or ≥1.
Health Plan Notification and Feedback to Providers is Associated with Increased Filling of Preventer Medications for Children with Asthma Enrolled in Medicaid
2008, Journal of PediatricsCitation Excerpt :Children were included in the cohort when they were enrolled in Medicaid between 2000 and 2002 and met the definition of moderate-severe asthma, which we considered to meet the requirements for recommendations for daily preventer medication use (Figure 1).19 The definition was drawn from earlier literature and included children who had an asthma hospitalization or asthma emergency department visit during the study period and frequent use of asthma medications in the 180 days before the asthma hospitalization or emergency department visit.20,21 Asthma hospitalizations were defined as a child having an inpatient claim during the study period with a primary diagnosis ICD-9-CM code for asthma (493.
Presented at the 68th Annual International Scientific Assembly of the American College of Chest Physicians, San Diego, California, November 2–7, 2002, and published in abstract form in Chest. 2002;122(4 suppl):54S.